Page 2 - Amrx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Amrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Amrx Today - Breaking & Trending Today

Amneal Pharmaceuticals (NASDAQ:AMRX) Trading Down 6.4%

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) fell 6.4% during trading on Tuesday . The company traded as low as $5.45 and last traded at $5.45. 697,403 shares traded hands during mid-day trading, a decline of 45% from the average session volume of 1,278,588 shares. The stock had previously closed at $5.82. Wall Street […] ....

United States , Hong Kong , Y Intercept Hong Kong Ltd , News Ratings For Amneal Pharmaceuticals Daily , Amneal Pharmaceuticals Company Profile , Pricet Rowe Associates Inc , Tower Research Capital , American Century Companies Inc , Amneal Pharmaceuticals Inc , Amneal Pharmaceuticals , Institutional Investors Weigh In On Amneal Pharmaceuticals , Amneal Pharmaceuticals Trading Down , Get Free Report , Pharmaceuticals Trading Down , Century Companies , Gate Manager , Research Capital , Amneal Pharmaceuticals Daily , Nasdaq Amrx ,

Amneal Pharmaceuticals (NASDAQ:AMRX) Shares Down 6.4%

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report)’s share price traded down 6.4% during trading on Tuesday . The stock traded as low as $5.45 and last traded at $5.45. 697,403 shares traded hands during trading, a decline of 45% from the average session volume of 1,278,588 shares. The stock had previously closed at $5.82. […] ....

Swiss National Bank , News Ratings For Amneal Pharmaceuticals Daily , York Mellon Corp , Amneal Pharmaceuticals Trading Down , Institutional Investors Weigh In On Amneal Pharmaceuticals , Amneal Pharmaceuticals Inc , Amneal Pharmaceuticals , Metlife Investment Management , Blackrock Inc , Panagora Asset Management Inc , Get Free Report , Truist Financial , Pharmaceuticals Trading Down , National Bank , New York Mellon Corp , Life Investment Management , Asset Management , Amneal Pharmaceuticals Daily , Nasdaq Amrx ,

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives Average Recommendation of "Moderate Buy" from Analysts

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) has been given an average recommendation of “Moderate Buy” by the five research firms that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month target […] ....

Hong Kong , United States , Tower Research Capital , Amneal Pharmaceuticals Trading , Pricet Rowe Associates Inc , Y Intercept Hong Kong Ltd , News Ratings For Amneal Pharmaceuticals Daily , American Century Companies Inc , Analyst Recommendations For Amneal Pharmaceuticals , Amneal Pharmaceuticals Inc , Institutional Trading Of Amneal Pharmaceuticals , Amneal Pharmaceuticals , Get Free Report , Century Companies , Gate Manager , Research Capital , Get Free , Amneal Pharmaceuticals Daily , Nasdaq Amrx ,

Tejara Capital Ltd Purchases New Stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)

Tejara Capital Ltd purchased a new stake in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 96,672 shares of the company’s stock, valued at approximately $408,000. A number of […] ....

Tejara Capital Ltd , Amneal Pharmaceuticals Stock Performance , Exchange Commission , Amneal Pharmaceuticals Inc , Jump Financial , Charles Schwab Investment Management Inc , Amneal Pharmaceuticals Company Profile , Quarter For Amneal Pharmaceuticals , News Ratings For Amneal Pharmaceuticals Daily , Amneal Pharmaceuticals , Free Report , Schwab Investment Management , Visit Holdingschannel , Amneal Pharmaceuticals Daily , Nasdaq Amrx , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,